• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微波消融与经导管动脉栓塞治疗大型肝血管瘤的临床疗效

Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes.

作者信息

Shi Yaoping, Song Jingjing, Ding Min, Tang Xiaoyin, Wang Zhi, Chi Jiachang, Wang Tao, Ji Jiansong, Zhai Bo

机构信息

Department of Interventional Oncology, School of Medicine, Renji Hospital, Shanghai Jiao-tong University, Shanghai, China.

Department of Radiology, Lishui Central Hospital, The Fifth Affiliated Hospital of Wenzhou Medical College, Lishui, China.

出版信息

Int J Hyperthermia. 2020;37(1):938-943. doi: 10.1080/02656736.2020.1766122.

DOI:10.1080/02656736.2020.1766122
PMID:32762267
Abstract

PURPOSE

To evaluate the safety and effect of microwave ablation (MWA) compared with transcatheter arterial embolization (TAE) for the treatment of large hepatic hemangiomas.

MATERIALS AND METHODS

A total of 135 patients with symptomatic or/and enlarging hepatic hemangiomas (5-10 cm) from two centers underwent either MWA ( = 82) or TAE ( = 53) as first-line treatment. We compared the two groups in terms of radiologic response, clinical response, operative time, postoperative analgesic requirements, hospital stay and complications.

RESULTS

MWA had a significantly higher rate of complete radiologic response (89.0% vs. 37.7%, <.001) and complete clinical response (88.6% vs. 69.2%, =.046), fewer minor complications (43.9% vs. 66.0%, =.019), shorter time of using analgesics (<.001) and shorter hospital stays (=.003) than did TAE. The operative time and major complications were comparable between the two groups.

CONCLUSION

Both MWA and TAE are safe and effective in treating patients with large hepatic hemangiomas. MWA had a higher rate of complete response than did TAE, and it was associated with fewer minor complications, faster recovery and shorter hospital stay.

摘要

目的

评估微波消融(MWA)与经导管动脉栓塞术(TAE)治疗大型肝血管瘤的安全性和疗效。

材料与方法

来自两个中心的135例有症状或/和血管瘤增大(5 - 10厘米)的患者接受了MWA(n = 82)或TAE(n = 53)作为一线治疗。我们比较了两组在影像学反应、临床反应、手术时间、术后镇痛需求、住院时间和并发症方面的情况。

结果

与TAE相比,MWA的完全影像学反应率显著更高(89.0%对37.7%,P <.001)和完全临床反应率更高(88.6%对69.2%,P =.046),轻微并发症更少(43.9%对66.0%,P =.019),使用镇痛药时间更短(P <.001)且住院时间更短(P =.003)。两组的手术时间和主要并发症相当。

结论

MWA和TAE在治疗大型肝血管瘤患者方面都是安全有效的。MWA的完全缓解率高于TAE,且并发症少、恢复快、住院时间短。

相似文献

1
Microwave ablation versus transcatheter arterial embolization for large hepatic hemangiomas: clinical outcomes.微波消融与经导管动脉栓塞治疗大型肝血管瘤的临床疗效
Int J Hyperthermia. 2020;37(1):938-943. doi: 10.1080/02656736.2020.1766122.
2
Outcomes of ultrasound-guided percutaneous microwave ablation versus surgical resection for symptomatic large hepatic hemangiomas.超声引导经皮微波消融与手术切除治疗有症状的大肝血管瘤的疗效比较。
Int J Hyperthermia. 2019;36(1):632-639. doi: 10.1080/02656736.2019.1624837.
3
Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.微波与射频消融治疗大型肝血管瘤的安全性和有效性:一项倾向评分匹配的多中心回顾性研究
Eur Radiol. 2022 May;32(5):3309-3318. doi: 10.1007/s00330-021-08425-4. Epub 2022 Jan 29.
4
Computed Tomography-Guided Radiofrequency Ablation Following Transcatheter Arterial Embolization in Treatment of Large Hepatic Hemangiomas.经导管动脉栓塞术后CT引导下射频消融治疗大型肝血管瘤
Medicine (Baltimore). 2016 Apr;95(15):e3402. doi: 10.1097/MD.0000000000003402.
5
Efficacy, safety and feasibility of ultrasound-guided percutaneous microwave ablation for large hepatic hemangioma.超声引导下经皮微波消融治疗巨大肝血管瘤的疗效、安全性及可行性
J Dig Dis. 2015 Sep;16(9):525-30. doi: 10.1111/1751-2980.12169.
6
Comparison of laparoscopic radiofrequency ablation versus open resection in the treatment of symptomatic-enlarging hepatic hemangiomas: a prospective study.腹腔镜射频消融术与开放性切除术治疗有症状且不断增大的肝血管瘤的比较:一项前瞻性研究
Surg Endosc. 2016 Feb;30(2):756-763. doi: 10.1007/s00464-015-4274-y. Epub 2015 Jun 27.
7
Combined trans-arterial embolisation and microwave ablation for the treatment of large unresectable hepatic metastases (>3 cm in maximal diameter).联合经动脉栓塞和微波消融治疗无法切除的大肝转移瘤(最大直径>3cm)。
Int J Hyperthermia. 2020;37(1):1395-1403. doi: 10.1080/02656736.2020.1849823.
8
Feasibility, safety, and efficacy of ultrasound-guided percutaneous microwave ablation for giant hepatic hemangioma.超声引导经皮微波消融治疗巨大肝血管瘤的可行性、安全性和有效性。
Int J Hyperthermia. 2018;35(1):246-252. doi: 10.1080/02656736.2018.1493541. Epub 2018 Aug 21.
9
Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.新辅助经动脉单纯化疗栓塞和药物洗脱微球化疗栓塞治疗肝细胞癌后射频消融与微波消融的比较
Curr Probl Diagn Radiol. 2017 Nov-Dec;46(6):402-409. doi: 10.1067/j.cpradiol.2017.02.006. Epub 2017 Feb 20.
10
Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response.经导管动脉栓塞联合博来霉素-碘油治疗肝血管瘤:安全性、疗效及反应预测因素
Cardiovasc Intervent Radiol. 2024 Jul;47(7):931-942. doi: 10.1007/s00270-024-03690-4. Epub 2024 Mar 20.

引用本文的文献

1
Thermal Ablation for Giant Hepatic Hemangiomas: A Meta-Analysis with Subgroup Analysis of Microwave and Radiofrequency Ablation Techniques.巨大肝血管瘤的热消融治疗:微波与射频消融技术亚组分析的Meta分析
Cardiovasc Intervent Radiol. 2025 Aug 29. doi: 10.1007/s00270-025-04172-x.
2
Efficacy and safety of transcatheter arterial chemoembolization combined with microwave ablation for hepatic hemangiomas (> 5 cm).经导管动脉化疗栓塞联合微波消融治疗直径>5cm肝血管瘤的疗效与安全性
World J Gastroenterol. 2025 Jul 28;31(28):109078. doi: 10.3748/wjg.v31.i28.109078.
3
LASSO Logistic Regression for Predicting Postoperative Severe Pain After Hepatic Hemangioma Ablation.
用于预测肝血管瘤消融术后严重疼痛的套索逻辑回归分析
J Pain Res. 2025 Apr 9;18:1909-1921. doi: 10.2147/JPR.S510668. eCollection 2025.
4
Reconsideration of the clinical management of hepatic hemangioma.肝血管瘤临床管理的重新审视。
World J Gastrointest Surg. 2024 Nov 27;16(11):3623-3628. doi: 10.4240/wjgs.v16.i11.3623.
5
Risk factors analysis of surgical complications of hepatic hemangioma: a modified Clavien-Dindo classification-based study.肝血管瘤手术并发症的风险因素分析:基于改良的 Clavien-Dindo 分级的研究。
BMC Surg. 2023 May 6;23(1):111. doi: 10.1186/s12893-023-02009-3.
6
Ablation for Benign Liver Tumors: Current Concepts and Limitations.良性肝脏肿瘤的消融治疗:当前概念与局限性
J Clin Transl Hepatol. 2023 Feb 28;11(1):244-252. doi: 10.14218/JCTH.2022.00205. Epub 2022 Sep 6.
7
Ultrasound-guided percutaneous sclerotherapy versus surgical resection in the treatment of large hepatic hemangiomas: a retrospective study.超声引导经皮硬化治疗与手术切除治疗巨大肝血管瘤的疗效对比:一项回顾性研究。
BMC Surg. 2022 Apr 7;22(1):130. doi: 10.1186/s12893-022-01574-3.
8
To Systematically Evaluate and Analyze the Efficacy and Safety of Transcatheter Arterial Chemoembolization (TACE) in the Treatment of Primary Liver Cancer.系统评价经导管肝动脉化疗栓塞术(TACE)治疗原发性肝癌的疗效及安全性。
J Healthc Eng. 2022 Mar 21;2022:8223336. doi: 10.1155/2022/8223336. eCollection 2022.
9
Safety and efficacy of microwave versus radiofrequency ablation for large hepatic hemangioma: a multicenter retrospective study with propensity score matching.微波与射频消融治疗大型肝血管瘤的安全性和有效性:一项倾向评分匹配的多中心回顾性研究
Eur Radiol. 2022 May;32(5):3309-3318. doi: 10.1007/s00330-021-08425-4. Epub 2022 Jan 29.